Livzon Pharmaceutical Announces Director Resignation
Company Announcements

Livzon Pharmaceutical Announces Director Resignation

Livzon Pharmaceutical Group (HK:1513) has released an update.

Livzon Pharmaceutical Group Inc. announced the resignation of Mr. Yu Xiong, a non-executive director, effective from 14 October 2024. His departure, due to work adjustment, is amicable with no disagreements or concerns for shareholders. The company will promptly hold a re-election for his successor in compliance with legal and internal guidelines.

For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Reports Mixed Q3 2024 Financial Results
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Proposes New Non-Executive Director
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Group Plans Key Meeting for 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App